Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Leases (2019 - 2025)

Historic Capital Leases for Nutex Health (NUTX) over the last 7 years, with Q3 2025 value amounting to $270.1 million.

  • Nutex Health's Capital Leases rose 1210.04% to $270.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.1 million, marking a year-over-year increase of 1210.04%. This contributed to the annual value of $259.5 million for FY2024, which is 2131.64% up from last year.
  • Per Nutex Health's latest filing, its Capital Leases stood at $270.1 million for Q3 2025, which was up 1210.04% from $258.0 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Capital Leases ranged from a high of $270.1 million in Q3 2025 and a low of $65.7 million during Q4 2021
  • Over the past 5 years, Nutex Health's median Capital Leases value was $221.4 million (recorded in 2023), while the average stood at $220.8 million.
  • Its Capital Leases has fluctuated over the past 5 years, first soared by 20975.61% in 2022, then crashed by 866.88% in 2024.
  • Quarter analysis of 5 years shows Nutex Health's Capital Leases stood at $65.7 million in 2021, then surged by 209.76% to $203.6 million in 2022, then grew by 5.04% to $213.9 million in 2023, then grew by 21.32% to $259.5 million in 2024, then increased by 4.08% to $270.1 million in 2025.
  • Its last three reported values are $270.1 million in Q3 2025, $258.0 million for Q2 2025, and $258.4 million during Q1 2025.